Chapter 13 — Case Study 2: The SN vs E Decision in Enzyme Active Sites
How biology orchestrates substitution vs. elimination at the active site by controlling the stereoelectronic environment.
1. The biological version of the decision
Biology rarely uses alkyl halides — too reactive in aqueous physiology. Instead, biology activates leaving groups in other ways: - Phosphates and pyrophosphates as leaving groups (high-energy bonds). - Sulfonium ions (SAM-like methyl donors). - Tosylate-equivalents under enzyme catalysis. - Activated C–N bonds in some cases.
The same substitution-vs-elimination decision applies to all of these. An enzyme can promote either pathway by controlling the active-site geometry, the available nucleophiles, the deprotonation of β-H, and the local pH/electrostatics.
2. Carbohydrate chemistry: SN vs E choices
Glycosyl transferases (Chapter 11 case study) catalyze SN1-like substitution at the anomeric C of sugars. The same enzyme family, with different substrate orientation, can also catalyze elimination — converting a sugar to a glycal or to a different sugar.
Example: pyranose ring opening. Some enzymes open the cyclic hemiacetal of glucose to give the open-chain aldehyde (an E-like ring-opening). Other enzymes do substitution at C1 to make a glycoside. Same substrate, different enzymes, different outcomes — controlled by the active-site environment.
Example: glycoside hydrolases. These enzymes cleave glycosidic bonds. Some go through substitution (adding water to the glycosidic carbon, $S_N$ at C1). Others go through "elimination" mechanisms producing an unsaturated intermediate. The choice depends on the enzyme's structure.
3. Amino acid metabolism
Free amino acids and their derivatives undergo many reactions where SN/E decisions matter:
Threonine deaminase (E1cb-like): the enzyme removes the α-H of threonine and eliminates ammonia (a nitrogen-containing leaving group activated to leave). Mechanism is E1cb: deprotonation gives a carbanion stabilized by an enamine intermediate, which loses ammonia to give an α,β-unsaturated carbonyl. The enzyme prevents racemization (which would happen if the carbanion just sat there), holds the substrate in proper geometry, and uses pyridoxal phosphate (PLP) as a cofactor to stabilize the carbanion.
Aminotransferases (substitution-like): different enzymes that swap an α-amino group for an α-keto group. Instead of E1cb, this is more like a substitution at the α-C with the help of PLP.
Threonine aldolase (substitution at α-C of threonine + cleavage): a cleavage reaction that decomposes threonine into glycine + acetaldehyde. Mechanism involves α-C reactivity and a C-C bond cleavage.
In each case, the same substrate can do multiple things; the enzyme controls which.
4. Citric acid cycle reactions
Several Krebs cycle steps involve SN or E decisions:
Aconitase (E + addition cycle): citrate ↔ isocitrate via cis-aconitate. This is two steps — first elimination of water from citrate to give the alkene cis-aconitate; then re-addition of water to give isocitrate. Mechanism: the elimination is E1cb-like; the addition is the reverse.
Fumarase: malate → fumarate + water (forward) or vice versa. Standard E1cb mechanism. Stereospecific (anti-elimination geometry forced by the enzyme).
Succinyl-CoA synthetase: a coenzyme-A-thioester is hydrolyzed (substitution at the carbonyl carbon, generating ATP). Different mechanism family but conceptually similar.
5. Fatty acid biosynthesis: another SN/E decision
In fatty acid biosynthesis, each cycle of chain extension includes:
Step 1 (substitution): Claisen condensation. Enolate (carbanion of an acetyl-CoA-like) attacks an electrophilic carbonyl carbon. Substitution-like.
Step 2 (reduction): hydride from NADPH adds to the β-keto carbonyl. Substitution-like.
Step 3 (dehydration / elimination): β-hydroxy carbonyl → α,β-unsaturated carbonyl + water. E1cb mechanism: the enzyme removes the α-H first, then the β-OH leaves.
Step 4 (reduction): another hydride from NADPH reduces the alkene to an alkane.
The third step is a textbook elimination. The enzyme accelerates it by ~10⁹ over the uncatalyzed reaction.
6. Why biology uses E1cb (not E2 or E1)
Most biological eliminations use the E1cb mechanism — a stepwise reaction through a stabilized carbanion intermediate. This is different from textbook E1 (which goes through a carbocation) or E2 (concerted).
Why E1cb in biology?
- Carbanions can be stabilized by electron-withdrawing groups (especially carbonyl groups and pyridoxal phosphate), making them accessible at moderate pH.
- Cations (E1) are usually too unstable in water without enzyme stabilization.
- E2 (concerted) requires precise geometry that an enzyme can provide, but E1cb is often easier to engineer.
The key insight: enzymes pick the mechanism that fits the active site's chemistry. The decision framework you learned in Chapter 13 translates: "which mechanism do these conditions favor?" In biology, the enzyme creates the conditions.
7. Drug design: exploiting these mechanisms
Pharmaceutical drug discovery often targets enzymes that use SN or E mechanisms:
Inhibitors of glycosyl transferases (some antifungals, some anticancer drugs). Inhibitors of dehydratases (anti-inflammatory drugs that block fatty acid biosynthesis). PLP-dependent enzyme inhibitors (some antiepileptics; vigabatrin inhibits GABA aminotransferase).
Designing these inhibitors requires understanding the mechanism — including whether the target reaction is SN or E. Chapter 13's framework is a starting point.
8. The lesson for Chapter 13
In synthetic chemistry, the chemist tunes the conditions (substrate, base, solvent, T) to get the desired mechanism. In biology, evolution tunes the enzyme to do the same job.
The chemistry — the underlying mechanism — is the same. The constraint is the same: substrate-base-environment combinations dictate outcome. The framework is just as predictive in biology as in the test tube.
When you see an enzyme reaction described as "substitution" or "elimination" in a biochemistry textbook, recognize that the same SN/E thinking applies. The enzyme is the catalyst, but the chemistry it accelerates follows the same rules you learned in Chapter 13.
Further reading: - Frey, P. A., and Hegeman, A. D. (2007). Enzymatic Reaction Mechanisms. Oxford University Press. - Christianson, D. W. (2017). Structural and chemical biology of terpenoid cyclases. Chem. Rev. 117, 11570. - Lairson, L. L., et al. (2008). Glycosyltransferases: structures, functions, mechanisms. Annu. Rev. Biochem. 77, 521. - Walsh, C. T. (1979). Enzymatic Reaction Mechanisms. Freeman. (Older but classic.)